JP2023535725A5 - - Google Patents
Info
- Publication number
- JP2023535725A5 JP2023535725A5 JP2023504544A JP2023504544A JP2023535725A5 JP 2023535725 A5 JP2023535725 A5 JP 2023535725A5 JP 2023504544 A JP2023504544 A JP 2023504544A JP 2023504544 A JP2023504544 A JP 2023504544A JP 2023535725 A5 JP2023535725 A5 JP 2023535725A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- prodrug
- solvate
- acceptable salt
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063055970P | 2020-07-24 | 2020-07-24 | |
| US63/055,970 | 2020-07-24 | ||
| PCT/US2021/042874 WO2022020661A1 (en) | 2020-07-24 | 2021-07-23 | Inhibitors of interleukin-1 receptor-associated kinases 1 and 4 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023535725A JP2023535725A (ja) | 2023-08-21 |
| JP2023535725A5 true JP2023535725A5 (https=) | 2024-07-22 |
| JP7769404B2 JP7769404B2 (ja) | 2025-11-13 |
Family
ID=77338897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504544A Active JP7769404B2 (ja) | 2020-07-24 | 2021-07-23 | インターロイキン－１受容体関連キナーゼ１及び４の阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230295146A1 (https=) |
| EP (1) | EP4185568A1 (https=) |
| JP (1) | JP7769404B2 (https=) |
| CN (1) | CN116057051B (https=) |
| AU (1) | AU2021311811A1 (https=) |
| CA (1) | CA3186896A1 (https=) |
| WO (1) | WO2022020661A1 (https=) |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR900482A (fr) | 1942-12-17 | 1945-06-29 | Fides Gmbh | Condensateur électrostatique avec diélectrique consistant au moins partiellement en produits de transformation non conducteurs d'une armature |
| FR66979E (fr) | 1953-06-22 | 1957-11-04 | Glaenzer Spicer Sa | Support pour arbre rotatif |
| US5851795A (en) | 1991-06-27 | 1998-12-22 | Bristol-Myers Squibb Company | Soluble CTLA4 molecules and uses thereof |
| US6051227A (en) | 1995-07-25 | 2000-04-18 | The Regents Of The University Of California, Office Of Technology Transfer | Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| US5811097A (en) | 1995-07-25 | 1998-09-22 | The Regents Of The University Of California | Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| US5855887A (en) | 1995-07-25 | 1999-01-05 | The Regents Of The University Of California | Blockade of lymphocyte down-regulation associated with CTLA-4 signaling |
| JP2001523958A (ja) | 1997-03-21 | 2001-11-27 | ブライハム アンド ウィミンズ ホスピタル，インコーポレイテッド | 免疫療法のｃｔｌａ−４結合ペプチド |
| CZ302706B6 (cs) | 1998-12-23 | 2011-09-14 | Pfizer Inc. | Lidská monoklonální protilátka, farmaceutická kompozice tuto protilátku obsahující, bunecná linie produkující tuto protilátku, izolovaná molekula kódující težký nebo lehký retezec uvedené protilátky, hostitelská bunka obsahující tuto izolovanou molek |
| US6682736B1 (en) | 1998-12-23 | 2004-01-27 | Abgenix, Inc. | Human monoclonal antibodies to CTLA-4 |
| US7109003B2 (en) | 1998-12-23 | 2006-09-19 | Abgenix, Inc. | Methods for expressing and recovering human monoclonal antibodies to CTLA-4 |
| US7605238B2 (en) | 1999-08-24 | 2009-10-20 | Medarex, Inc. | Human CTLA-4 antibodies and their uses |
| EP1212422B1 (en) | 1999-08-24 | 2007-02-21 | Medarex, Inc. | Human ctla-4 antibodies and their uses |
| JP2003520828A (ja) | 2000-01-27 | 2003-07-08 | ジェネティクス インスティテュート，エルエルシー | Ｃｔｌａ４（ｃｄ１５２）に対する抗体、これを含む結合体、およびその使用 |
| BRPI0315295C1 (pt) | 2002-10-17 | 2021-05-25 | Genmab As | anticorpo monoclonal humano isolado, célula hospedeira procariótica, composição farmacêutica, molécula biespecífica, usos de um anticorpo, métodos in vitro de detectar a presença de antígeno de cd20 ou uma célula que expressa cd20 em uma amostra, kit, e, vetor de expressão |
| ES2422263T3 (es) * | 2008-12-19 | 2013-09-10 | Nerviano Medical Sciences Srl | Pirazoles bicíclicos como inhibidores de la proteinquinasa |
| JP2012254939A (ja) * | 2009-10-07 | 2012-12-27 | Astellas Pharma Inc | オキサゾール化合物 |
| US8987275B2 (en) * | 2010-03-16 | 2015-03-24 | Dana-Farber Cancer Institute, Inc. | Indazole compounds and their uses |
| WO2013042137A1 (en) * | 2011-09-19 | 2013-03-28 | Aurigene Discovery Technologies Limited | Bicyclic heterocycles as irak4 inhibitors |
| RU2730016C2 (ru) * | 2015-02-05 | 2020-08-14 | Мерк Патент Гмбх | Макроциклические соединения в качестве irak1/4 ингибиторов и их применение |
| AU2017363313B2 (en) * | 2016-11-22 | 2021-06-24 | Dana-Farber Cancer Institute, Inc. | Inhibitors of interleukin-1 receptor-associated kinases and uses thereof |
| EP3642201A1 (en) * | 2017-06-21 | 2020-04-29 | H. Hoffnabb-La Roche Ag | Isoindolinone derivatives as irak4 modulators |
| CA3068305A1 (en) * | 2017-06-29 | 2019-01-03 | Rigel Pharmaceuticals, Inc. | Kinase inhibitors and methods for making and using |
-
2021
- 2021-07-03 US US18/017,759 patent/US20230295146A1/en active Pending
- 2021-07-23 WO PCT/US2021/042874 patent/WO2022020661A1/en not_active Ceased
- 2021-07-23 CN CN202180054152.8A patent/CN116057051B/zh active Active
- 2021-07-23 EP EP21755252.0A patent/EP4185568A1/en active Pending
- 2021-07-23 CA CA3186896A patent/CA3186896A1/en active Pending
- 2021-07-23 JP JP2023504544A patent/JP7769404B2/ja active Active
- 2021-07-23 AU AU2021311811A patent/AU2021311811A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4440702B1 (en) | Therapeutic compounds for hiv virus infection | |
| JP2021523225A5 (https=) | ||
| EP2997019B1 (en) | Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b | |
| KR102399848B1 (ko) | 신규한 jak1 선택적 억제제 및 그 용도 | |
| TWI352695B (en) | Antiparasitic agents | |
| JP2011527686A5 (https=) | ||
| JP2014500870A5 (https=) | ||
| US12606525B2 (en) | Dimethyltryptamine analogues as nitric oxide delivery drugs | |
| CN1116283C (zh) | 作为细胞增殖抑制剂的氰基胍 | |
| JP2020090516A (ja) | 選択的アンドロゲン受容体モジュレーターとしてのカルボニトリル誘導体 | |
| TWI794856B (zh) | 製備具有經取代之苯基或吡啶基部分的ｓｅｒｄ三環化合物的方法 | |
| HK1224281A1 (zh) | 磷脂酰肌醇3-激酶抑制劑的製備方法 | |
| EP3489215A1 (en) | Process for producing organic compound | |
| EP3344603A1 (en) | A production method of 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin- 4 yl)urea and its deuterated analogs not containing dimeric impurities | |
| JP6795525B2 (ja) | 炭酸脱水酵素阻害剤としてのアリールスルホンアミド化合物およびその治療的使用 | |
| US12473305B2 (en) | Pyrazole boronic acid compound, pharmaceutical composition containing same, and uses thereof | |
| JP2023535725A5 (https=) | ||
| WO2018106200A1 (en) | Original drug molecules for the treatment of parasitic and neoplastic diseases and methods for preparation thereof | |
| AU2002331310B2 (en) | Novel aminobenzoephenones | |
| JP2022545181A5 (https=) | ||
| JP2024515739A5 (https=) | ||
| RU2818455C1 (ru) | Способы получения трициклических соединений serd, имеющих замещенный фенильный или пиридинильный фрагмент | |
| KR20220110795A (ko) | 2-(4-클로로페닐)-n-((2-(2,6-디옥소피페리딘-3-일)-1-옥소이소인돌린-5-일)메틸)-2,2-디플루오로아세트아미드의 제조 방법 | |
| CN114929664B (zh) | 基于氨氧基酸的抗癌干细胞化合物及其方法 | |
| JP2019531304A (ja) | 薬学的使用のための鏡像異性的に純粋なシス‐イミダゾリン化合物を生成するための合成方法 |